Collectively, our data illustrates that inhibition of AKT pathway in GIST and STS attenuates homology-mediated DNA repair and sensitizes tumor cells to the DNA-damaging agents, such as doxorubicin. The gene discussed is AKT1; the disease is gastrointestinal stromal tumor.